Gene · 4741
Papers1,719
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,719
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative Multi-Omics Analysis of Oncogenic EZH2 Mutants: From Epigenetic Reprogramming to Molecular Signatures. | Int J Mol Sci | 2023 | 37511137 | PubTator, text mining | PubMed |
| Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade. | Res Sq | 2023 | 37503252 | PubTator, text mining | PubMed |
| Neurofilament Expression as a Biomarker of Post-COVID-19 Sudden Sensorineural Hearing Loss. | Diseases | 2023 | 37489444 | PubTator, text mining | PubMed |
| Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer's disease. | Mol Neurodegener | 2023 | 37468915 | PubTator, text mining | PubMed |
| Mass Spectrometry as a Quantitative Proteomic Analysis Tool for the Search for Temporal Lobe Epilepsy Biomarkers: A Systematic Review. | Int J Mol Sci | 2023 | 37446307 | PubTator, text mining | PubMed |
| The Heterogeneous Multiple Sclerosis Lesion: How Can We Assess and Modify a Degenerating Lesion? | Int J Mol Sci | 2023 | 37446290 | PubTator, text mining | PubMed |
| Rotenone Blocks the Glucocerebrosidase Enzyme and Induces the Accumulation of Lysosomes and Autophagolysosomes Independently of LRRK2 Kinase in HEK-293 Cells. | Int J Mol Sci | 2023 | 37445771 | PubTator, text mining | PubMed |
| LRRK2 Knockout Confers Resistance in HEK-293 Cells to Rotenone-Induced Oxidative Stress, Mitochondrial Damage, and Apoptosis. | Int J Mol Sci | 2023 | 37445652 | PubTator, text mining | PubMed |
| Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges. | J Clin Med | 2023 | 37445309 | PubTator, text mining | PubMed |
| Concentrations of Serum Brain Injury Biomarkers Following SARS-CoV-2 Infection in Individuals with and without Long-COVID-Results from the Prospective Population-Based COVI-GAPP Study. | Diagnostics (Basel) | 2023 | 37443561 | PubTator, text mining | PubMed |
| Spatially resolved multiomics of human cardiac niches. | Nature | 2023 | 37438528 | PubTator, text mining | PubMed |
| Transcriptome-wide RNA binding analysis of C9orf72 poly(PR) dipeptides. | Life Sci Alliance | 2023 | 37438085 | PubTator, text mining | PubMed |
| Optic Nerve Head Gene Transcription Sequelae to a Single Elevated IOP Exposure Provides Insights Into Known Responses to Chronically Elevated IOP. | Invest Ophthalmol Vis Sci | 2023 | 37405758 | PubTator, text mining | PubMed |
| MicroRNA-29 differentially mediates preeclampsia-dysregulated cellular responses to cytokines in female and male fetal endothelial cells. | J Physiol | 2023 | 37401732 | PubTator, text mining | PubMed |
| Optimized screening of DNA methylation sites combined with gene expression analysis to identify diagnostic markers of colorectal cancer. | BMC Cancer | 2023 | 37400791 | PubTator, text mining | PubMed |
| What do we know about blood-testis barrier? current understanding of its structure and physiology. | Front Cell Dev Biol | 2023 | 37397257 | PubTator, text mining | PubMed |
| scRNA-Seq of Cultured Human Amniotic Fluid from Fetuses with Spina Bifida Reveals the Origin and Heterogeneity of the Cellular Content. | Cells | 2023 | 37371048 | PubTator, text mining | PubMed |
| Biomarkers in cerebrospinal fluid for amyotrophic lateral sclerosis phenotypes. | Ann Clin Transl Neurol | 2023 | 37350306 | PubTator, text mining | PubMed |
| Nutritional requirements of human induced pluripotent stem cells. | Stem Cell Reports | 2023 | 37315525 | PubTator, text mining | PubMed |
| Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer's Disease drug candidate. | Mol Neurodegener | 2023 | 37280636 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4741/papers?page=7